CYTOKINETICS INC — Director's Dealing 2020

May 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-05-01

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-01	Common Stock	S	5000	$14.3356	Disposed	304444	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2083	Indirect
Common Stock	2083	Indirect

Footnotes

F1: 5,000 shares disposed of is comprised of: (i) 908 shares of common stock purchased on 10/31/2016 pursuant to the Employee Stock Purchase Plan of Cytokinetics, Incorporated (the ?ESPP?), (ii) 795 shares of common stock purchased on 10/31/2017 pursuant to the ESPP, (iii) 859 shares of common stock purchased on 10/31/2018 pursuant to the ESPP, (iv) 1,117 shares of common stock purchased on 4/28/2017 pursuant to the ESPP, and (v) 1,321 shares of common stock purchased on 4/30/2018 pursuant to the ESPP.

F2: Includes 8,846 shares of common stock purchased pursuant to the ESPP.

F3: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F4: Shares held by The Brittany Blum 2003 Irrevocable Trust.